A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
FISH, AML, CBFB/MYH11, Inversion 16, Technical Component
Test Code37881
CPT Codes
88275, 88271 (x2)
Preferred Specimen
3 mL - 5 mL bone marrow or whole blood collected in a sodium heparin (green-top), (royal blue-top) or lead-free (tan-top) tube
Minimum Volume
1 mL
Instructions
Specimen viability decreases during transit. Send specimen to testing lab for viability.
Transport Temperature
Room temperature
Specimen Stability
Room temperature: See Instructions
Refrigerated: See Instructions
Frozen: See Instructions
Refrigerated: See Instructions
Frozen: See Instructions
Methodology
Fluorescence in-situ hybridization (FISH)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
A.M. Sets up 7 days a week.
Report Available
Reports in 5 to 7 days.
Clinical Significance
This test is performed to detect the CBFB rearrangements such as inversion (16) and translocation t(16:16), by FISH (fluorescence in situ hybridization). This assay is useful for diagnosis of acute myeloid leukemia (AML) with inv(16) or t(16;16); CBFB-MYH11.